跳至主要内容
临床试验/NCT07721818
NCT07721818尚未招募4 期

The Association Between Bilateral Intermediate Cervical Plexus Block and Salivary Biomarkers of Surgical Stress Response Following Total Thyroidectomy

University Hospital Dubrava0 个研究点目标入组 48 人开始时间: 2026年8月1日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
48
主要终点
Salivary IL-6 Concentration

研究概览

简要总结

The aim of this study is to evaluate how an ultrasound-guided bilateral intermediate cervical plexus block affects the surgical stress response in individuals undergoing total thyroidectomy. The primary objective is to quantify this physiological response through the analysis of specific stress and inflammatory biomarkers collected from the participants' saliva.

The clinical trial will encompass a total of 48 patients, randomized equally into two distinct cohorts of 24 participants each. The control group will undergo standard total intravenous anesthesia (TIVA), whereas the experimental group will receive the bilateral intermediate cervical plexus block in combination with the TIVA protocol.

It is hypothesized that integrating this regional nerve block with total intravenous anesthesia will significantly attenuate the surgical stress response, evidenced by a reduction in salivary biomarker concentration, compared to utilizing TIVA alone during thyroid surgery.

Validating this hypothesis would offer robust scientific evidence to advocate for the routine integration of the bilateral intermediate cervical plexus block into standard anesthetic practices for total thyroidectomy. Ultimately, this approach aims to minimize perioperative stress and facilitate a more rapid postoperative recovery for patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ASA I or ASA II
  • euthyroid status
  • signed informed consent

排除标准

  • patients who refuse to sign the informed consent form
  • infection at the block injection site
  • hypersensitivity or contraindications to the medication used in the study
  • hypo/hyperthyroidism at the time of surgery
  • presence of substernal goiter
  • additional surgical interventions during the procedure
  • history of previous neck surgery or radiation
  • coagulopathy
  • uncontroled respiratory disease
  • diabetes mellitus
  • autoimune disease
  • chronic corticosteroid therapy
  • pregnant women

研究组 & 干预措施

TIVA alone

No Intervention

TIVA + bilateral intermediate cervical plexus block with 0,25% levobupivacaine

Experimental

干预措施: Ultrasound guided bilateral intermediate cervical plexus block (Procedure)

结局指标

主要结局

Salivary IL-6 Concentration

时间窗: Baseline (preoperatively), 1 hour after the completion of surgery, and 24 hours after the completion of surgery

Unit of measure: pg/mL

Salivary Cortisol Concentration

时间窗: Baseline (preoperatively), 1 hour after the completion of surgery, and 24 hours after the completion of surgery

Unit of measure: nmol/L

Salivary Alpha-amylase Activity

时间窗: Baseline (preoperatively), 1 hour after the completion of surgery, and 24 hours after the completion of surgery

Unit of measure: U/L

次要结局

  • Total Intraoperative Sufentanyl Consumption(Intraoperative period)
  • Total Postoperative Analgetics consumption(During the first 24 hours after the completion of surgery)
  • Time to Rescue Analgesia(During the first 24 hours after the completion of surgery)
  • Hemodynamic Stability (heart rate)(Intraoperative period and during the first 24 hours after the completion of surgery)
  • Postoperative Sedation Level(During the first 4 hours after the completion of surgery)
  • Postoperative Nausea and Vomiting(During the first 24 hours after the completion of surgery)
  • Hemodynamic Stability (blood pressure)(Intraoperative period and during the first 24 hours after the completion of surgery)

研究者

发起方
University Hospital Dubrava
申办方类型
Other
责任方
Principal Investigator
主要研究者

Antonija Mihelcic

Anesthesiologist

University Hospital Dubrava

相似试验